A Proof-of-Concept Randomized Controlled Study of Gabapentin: Effects on Cannabis Use, Withdrawal and Executive Function Deficits in Cannabis-Dependent Adults - Mason, Barbara J; Crean, Rebecca; Goodell, Vivian; Light, John M; Quello, Susan; Shadan, Farhad; Buffkins, Kimberly; Kyle, Mark; Adusumalli, Murali; Begovic, Adnan; Rao, Santosh (Neuropsychopharmacology (New York, N.Y.), 2012)
Keywords: Abstinence; Addictions; Addictive behaviors; Adolescent; Adult; Adult and adolescent clinical studies; Amines - pharmacology; Amines - therapeutic use; Biological and medical sciences; Brain research; Calcium Channel Blockers - pharmacology; Calcium Channel Blockers - therapeutic use; Cannabis - adverse effects; Clinical trials; Counseling; Cyclohexanecarboxylic Acids - pharmacology; Cyclohexanecarboxylic Acids - therapeutic use; Desintoxication. Drug withdrawal; Double-Blind Method; Drug addiction; Drug therapy; Drug use; Drug withdrawal; Executive function; Executive Function - drug effects; FDA approval; Female; gamma-Aminobutyric Acid - pharmacology; gamma-Aminobutyric Acid - therapeutic use; Humans; Male; Marijuana; Marijuana Abuse - drug therapy; Marijuana Abuse - psychology; Marijuana Abuse - therapy; Medical sciences; Middle Aged; Neurosciences; Original; Pilot projects; Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Research centers; Substance Withdrawal Syndrome - drug therapy; Substance Withdrawal Syndrome - psychology; Substance Withdrawal Syndrome - therapy; Tetrahydrocannabinol; THC; Toxicology; Treatment Outcome; Treatments; La Jolla California; United States--US; Human; Drug addiction; cannabis dependence; Executive function; Poison withdrawal; Cognitive disorder; addiction treatment; Gabapentin; Controlled therapeutic trial; Cannabidaceae; Anticonvulsant; randomized controlled trial; Cannabis; Analgesic; Addiction; marijuana withdrawal; Dicotyledones; Angiospermae; Dependence; Adult; Marijuana; Spermatophyta; Drug of abuse; Recreational drug